Chat Highlights
Aqueous Shunts for Glaucoma
July 12, 2000
Norma Devine, Editor
On Wednesday, July 12, 2000,
Dr.
Rick Wilson, a glaucoma specialist at Wills, and the glaucoma
chat group discussed "Aqueous Shunts for Glaucoma."
Moderator: Good
evening, Dr. Wilson. Welcome back from your trip.
Shunts are on the agenda tonight.
Dr. Wilson: Forgive
me tonight if I'm a bit addled. It is 2:36 A.M. my
time, and I've been up since 2:00 A.M. your time.
P: What is a
shunt?
Dr. Wilson: A
shunt is a tiny silicone tube attached to a plate that is placed
back half way around the eye. The tube leads the eye fluid out
to the plate, where it is absorbed through the scar tissue surrounding
it.
P: What are shunts
used for?
Dr. Wilson: Shunts
are our second- or third-line defense for glaucoma requiring surgery
and are being used increasingly. Shunts don't result in
thin blebs that can leak or get infected, but they don't give
as low a pressure as trabeculectomies.
P: Was there
any particular reason I wasn't given a shunt?
Dr. Wilson: Trabeculectomy
is still our first-line procedure, unless the patient has
inflammatory or neovascular glaucoma or has conjunctiva so scarred
that a trabeculectomy cannot be done.
P: Are shunts
longer lasting than trabs? Are they more trouble-free?
Dr. Wilson: My
impression is that shunts often last longer. However, a recent
study revealed that shunts have a slow loss of effectiveness similar
to that exhibited by trabeculectomies. It used to
be said the average trab lasted seven years before it had to be
redone. With 5-FU and Mitomycin, they are definitely lasting longer.
So it may be a toss-up between shunts and trabs.
P: Is the surgery
tricky?
Dr. Wilson: Not
too bad, but the procedure takes about 10 minutes longer
than a trab.
Moderator: I
was told my eyes are too small for a shunt. Can that be?
Dr. Wilson: No.
Shunts are certainly more hazardous in cramped, small eyes (as
are trabs), but they can be done.
P: Are these
shunts the same basic idea as those used by neurosurgeons to relieve
pressure from intra-cranial bleeds?
Dr. Wilson: Yes.
P: Dr. Wilson,
are shunts used for children?
Dr. Wilson: Yes,
even infants, if need be.
Moderator: What about
nanophthalmic eyes?
Dr. Wilson: The
same. Shunts may be safer than trabs for nanophthalmic eyes.
P: Do shunts
make later trabs impossible? Or vice versa?
Dr. Wilson: The
latter is the most common.
P: How much do
shunts lower pressure?
Dr. Wilson: Eyes
with shunts usually end up with an IOP on average of from
15 to 25. It is common to have to use at least one medicine
with the shunt to get the IOP to an acceptable level.
P: Do you mean
15 to 25 with or without the additional medicine?
Dr. Wilson: I mean
15 to 25 without medication.
P: Perhaps you
could tell us the risks of shunts, or the side effects, other
than the pressure not being very low. I had double vision
and great discomfort with one brand, but am happy after
replacing it with the Baerveldt. I'm not promoting the product,
but the difference was considerable. I don't know why any
other kind would be used and would like to know if there are reasons
I had to suffer with another kind.
Dr. Wilson: Actually,
I recently had to remove a Baerveldt, which had caused double
vision. Other complications are rubbing of the tube on the
iris causing inflammation or on the cornea causing corneal swelling
and loss of clarity. The conjunctiva covering the shunt
can wear through, exposing the shunt to outside infection.
The drop in IOP caused by the tube opening up can cause
swelling or hemorrhage.
P: Is Baerveldt
a brand name or a style of shunt?
P: A brand name.
But also, there are different designs.
P: I have two
Baerveldt implants. The first ended up being a very miserable
experience and scarred up. The second Baerveldt has gone
incredibly smoothly. I don't know why.
Dr. Wilson: Baerveldts
and Ahmeds are the shunts most likely to cause double vision.
Ahmeds and Krupins are more likely to result in a higher IOP.
My favorite is the double-plate Molteno or the Baerveldt.
P: Doctor, I
was told that the large-sized Baerveldt did not offer enough extra
benefit to justify using it, and the medium was used. What
do you think?
Dr. Wilson: That
has been well shown in studies. The Baerveldt 500 has been
taken off the market because of the studies.
P: I can't really feel the implants themselves,
but they affect my eyes in weird ways. Directly after surgery
and for up to six months, I had a hard time getting my eyes to
work together. The right eye felt swollen and looked buggy,
waking up was difficult because it took a while to feel normal.
I have two very white patches of sclera over my tubes, but all
in all I feel better after a month from the second surgery than
I felt six months after the first.
P: Are shunts
used for individuals with normal tension glaucome (NTG)?
Dr. Wilson: Shunts
are not great for patients with NTG (normal-tension glaucoma)
since shunts have a hard time lowering IOP into the less than
15 mm Hg range.
Moderator: How
quickly is the pressure lowered?
Dr. Wilson: Shunts
that are not equipped with a one-way flow valve are tied off at
the time of surgery with a dissolvable tie. The tie dissolves
at about one month. Then there is a sudden drop in pressure
as the eye fluid runs out the tube and fills up the reservoirs.
If the eye is healthy and continues making fluid, the IOP
is again raised to normal. If the eye cannot make fluid
fast enough and the pressure becomes too low, there can be complications
of fluid build-up between the layers of the eye or there can be
bleeding.
P: Is the drop
in pressure with a shunt the reason shunts aren't made to produce
lower pressures?
Dr. Wilson: No,
it is the thickness of the scar tissue that builds up around the
shunt reservoir that determines the final IOP. Once the
shunt is big enough, most seem the same.
Moderator: Can
you give us a number as to the percentage of patients that have
complications?
Dr. Wilson: The
number varies dramatically, depending upon how sick the eye is
and what kind of glaucoma it has. Fewer than 25% have some
kind of complication, and most of those are not sight- or life-threatening.
P: How does the
under 25% complication rate compare with the rate of complications
with trabs?
Dr. Wilson: There
are more complications, but the success rate is higher with
shunts in recalcitrant glaucoma.
P: What is recalcitrant glaucoma?
Dr. Wilson: Glaucoma
that's very hard to control.
P: Do you have
to know that certain drops will lower your pressure before you
can have a shunt?
Dr. Wilson: It
is helpful to know that ahead of time.
P: Then shunts
wouldn't work for me, because no eye drops lower my pressure.
I guess I will never be able to have shunts.
Dr. Wilson: Hopefully,
shunts and other surgeries will be better by the time you need
anything else. New medicines are coming out more commonly
now.
P: Do you have
any information about fatigue that will help me?
Dr. Wilson: Alphagan
commonly causes fatigue. Beta blockers may also cause fatigue.
Xalatan can cause joint pain.
P: How about
Ocupress?
Dr. Wilson: Ocupress
is a mild beta blocker.
P: I wish a doctor
had taken me off beta blockers as an experiment, to see if I felt
any different. I think its the only way for patients to
know, unless the effects are felt as extreme.
P: I make sure
to occlude my tear duct, now that I am on Betoptic in both eyes.
P: Are kids who
have had trabs at increased risk for infection in ocean
water vs. chlorinated pool water?
Dr. Wilson: The
more contaminated the water, the greater the risk.
However, the risk depends entirely upon the appearance of the
bleb. If the bleb is thin and there are no vessels over
it, there is real risk. If the bleb is thin and well vascularized,
then the risk from swimming is minimal. Night all.
My head just missed the keys. Have a great week and summer.
End of highlights for July 12th chat.
Click here to read more about Aqueous
Shunts.
On July 19th, Dr. Rick Wilson discussed "Testing in Glaucoma"
in the Chat room. Click here for highlights
of that meeting.
Click here for the most recent
glaucoma chat highlights and links to the chat archives.
Click here for
upcoming glaucoma chat events.
|